Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Labrie

Showing results (491-500 of 723) with videos related to

Pageof 73
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 1, 1994
Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiencyR Sanchez, E Rhéaume, N Laflamme, et al.
Endocrinology|October 1, 1989
Inhibitory effect of androgen on estrogen-induced prolactin messenger ribonucleic acid accumulation in the male rat anterior pituitary glandY Tong, J Simard, C Labrie, et al.
Molecular and Cellular Endocrinology|June 1, 1981
Parallel stimulation of ACTH, beta-LPH + beta-endorphin and alpha-MSH release by alpha-adrenergic agents in rat anterior pituitary cells in cultureV Raymond, J Lépine, V Giguère, et al.
Journal of Cyclic Nucleotide Research|January 1, 1975
Parellel inhibition of LH-RH-induced cyclic AMP accumulation and LH and FSH release by LH-RH antagonists in vitroM Beaulieu, F Labrie, D H Coy, et al.
Cytogenetics and Cell Genetics|January 1, 1996
Genetic linkage mapping of the human steroid 5 alpha-reductase type 2 gene (SRD5A2) close to D2S352 on chromosome region 2p23-->p22J Morissette, F Durocher, J F Leblanc, et al.
Annales D'Urologie|January 1, 1986
[Combined anti-androgen treatment in adenocarcinoma of the prostate: first use of a new therapeutically efficacious principle in hormone-dependent cancer]F Labrie, A Dupont, A Bélanger, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 12, 1998
Regulation of sex steroid formation by interleukin-4 and interleukin-6 in breast cancer cellsC Turgeon, S Gingras, M C Carrière, et al.
Journal of the National Cancer Institute|March 1, 1977
Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumorsP A Kelly, J Asselin, M G Caron, et al.
Endocrinology|May 16, 1998
Effect of twenty-four-week treatment with the antiestrogen EM-800 on estrogen-sensitive parameters in intact and ovariectomized miceS Luo, A Sourla, C Labrie, et al.
Clinical Endocrinology|January 1, 1986
Loss of luteinizing hormone bioactivity in patients with prostatic cancer treated with an LHRH agonist and a pure antiandrogenR St-Arnaud, R Lachance, S J Kelly, et al.
Pageof 73

Showing results (491-500 of 723) with videos related to

Sort By:
Pageof 73
The Journal of Clinical Endocrinology and Metabolism|March 1, 1994
Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiencyR Sanchez, E Rhéaume, N Laflamme, et al.
Endocrinology|October 1, 1989
Inhibitory effect of androgen on estrogen-induced prolactin messenger ribonucleic acid accumulation in the male rat anterior pituitary glandY Tong, J Simard, C Labrie, et al.
Molecular and Cellular Endocrinology|June 1, 1981
Parallel stimulation of ACTH, beta-LPH + beta-endorphin and alpha-MSH release by alpha-adrenergic agents in rat anterior pituitary cells in cultureV Raymond, J Lépine, V Giguère, et al.
Journal of Cyclic Nucleotide Research|January 1, 1975
Parellel inhibition of LH-RH-induced cyclic AMP accumulation and LH and FSH release by LH-RH antagonists in vitroM Beaulieu, F Labrie, D H Coy, et al.
Cytogenetics and Cell Genetics|January 1, 1996
Genetic linkage mapping of the human steroid 5 alpha-reductase type 2 gene (SRD5A2) close to D2S352 on chromosome region 2p23-->p22J Morissette, F Durocher, J F Leblanc, et al.
Annales D'Urologie|January 1, 1986
[Combined anti-androgen treatment in adenocarcinoma of the prostate: first use of a new therapeutically efficacious principle in hormone-dependent cancer]F Labrie, A Dupont, A Bélanger, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 12, 1998
Regulation of sex steroid formation by interleukin-4 and interleukin-6 in breast cancer cellsC Turgeon, S Gingras, M C Carrière, et al.
Journal of the National Cancer Institute|March 1, 1977
Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumorsP A Kelly, J Asselin, M G Caron, et al.
Endocrinology|May 16, 1998
Effect of twenty-four-week treatment with the antiestrogen EM-800 on estrogen-sensitive parameters in intact and ovariectomized miceS Luo, A Sourla, C Labrie, et al.
Clinical Endocrinology|January 1, 1986
Loss of luteinizing hormone bioactivity in patients with prostatic cancer treated with an LHRH agonist and a pure antiandrogenR St-Arnaud, R Lachance, S J Kelly, et al.
Pageof 73